SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported a loss of $13.5 million in its first quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 8 cents.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 9 cents per share.
The drug developer posted revenue of $26.1 million in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $24.3 million.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RIGL at https://www.zacks.com/ap/RIGL
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.